| Allison Leigh Ellington, | |
|
1410 N Augusta St, Staunton, VA 24401-2401 | |
| (540) 886-6233 | |
| Not Available |
| Full Name | Allison Leigh Ellington |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1410 N Augusta St, Staunton, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356787915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119004652 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allison Leigh Ellington, 1410 N Augusta St, Staunton, VA 24401-2401 Ph: (540) 886-6233 | Allison Leigh Ellington, 1410 N Augusta St, Staunton, VA 24401-2401 Ph: (540) 886-6233 |
News Archive
Increased brain cell activity boosts brain fluid levels of a protein linked to Alzheimer's disease, according to new research from scientists at Washington University School of Medicine in St. Louis.
The American Society for Radiation Oncology is continuing its commitment to Target Safely, a six-point patient protection plan developed in January 2010, to improve the safety and quality of radiation therapy treatments and reduce the chances of medical errors.
Poor perceptions about workplace safety culture among emergency medical services (EMS) workers is associated with negative patient and provider safety outcomes - the first time such a link has been shown in the pre-hospital setting, according to a study by University of Pittsburgh researchers that now appears online in Prehospital Emergency Care and is scheduled to be published in the January-March print edition.
Count Me In, a nonprofit cancer research initiative, is inviting all patients across the United States and Canada who have ever been diagnosed with colorectal cancer to participate in research and help drive new discoveries related to this disease.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
› Verified 9 days ago
Valerie Hope Lovinger, OTR/L Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 512 Houston St, Staunton, VA 24401 Phone: 540-886-2335 | |
Kelly S Lum, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 102 Business Way, Staunton, VA 24401 Phone: 540-886-5777 Fax: 540-886-5776 | |
Virginia Hand And Rehabilitation Services, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 107 Mactanly Pl, Staunton, VA 24401 Phone: 540-885-1177 Fax: 540-885-5856 | |
Linda Slota Ostrander, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 302 Buchanan St, Staunton, VA 24401 Phone: 540-887-8007 Fax: 540-887-8004 | |
Marla Mandujano, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 New Hope Rd, Staunton, VA 24401 Phone: 540-332-9000 | |
Melissa Anne Garner Lasley, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 512 Houston St, Staunton, VA 24401 Phone: 540-886-2335 |